Summary

Report Scope
This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.
In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy. The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.
The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region’s leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.
Report Includes
- 48 data tables and 56 additional tables
- Analysis of the global market for conventional and alternative pain treatments
- Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
- A Porter’s Five Forces analysis, a global supply chain analysis and a SWOT analysis
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- A look at recent patent grants
- Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
- Profiles of market leaders, including Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview of Types of Pain and Its Treatment
Introduction
The Perception of Pain
How Pain is Treated
Pain Management Techniques: Electrical Stimulation
Pain Management Procedures
Alternative Methods of Pain Management
Growing Trend in Cannabis Treatment for Pain
Treatment Using Alternatives for Chronic Pain
Chapter 3 Market Dynamics
Introduction
Market Drivers
Rise in the Aging Population
Increasing Integration of Artificial Intelligence in Medical Devices
Rising Incidence of Chronic Diseases
Growth of Public Health Programs That Address Chronic Pain
Improvement in the Non-Drug Techniques
Market Restraints
Failure in Medical Device Designs
Supply Chain Issues and Quality Concerns
Market Opportunities
Expanding Usage of Wearable Devices
Technological Development for Conventional and Alternative Pain Treatment
Future Trends and Possibilities
Chapter 4 Emerging Technologies and Developments
Introduction
Regenerative Medicine
Advantages of Regenerative Pain Management
Minuteman Procedure
Peripheral Nerve Stimulation (PNS)
VIA Disc Treatment
Other Technologies
Wearable Devices and Biofeedback
Virtual Reality (VR) Therapy
Artificial Intelligence (AI) in Pain Prediction
Pain Management Clinical Trials
Trends in Development of Conventional and Alternative Pain Treatment
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Pain Management Type
Market Size and Forecast
Pharmaceuticals/Drug Therapy
Market Size and Forecast
Non-Narcotic Analgesics
Medical Cannabis
Narcotic Analgesics
Antimigraine Agents
Central Nervous System (CNS) Treatments
Anesthetics
Other Classes
Devices
Market Size and Forecast
Spine Stimulators
Electrotherapy/Muscle Stimulation
Other Devices
Market Breakdown by Application
Market Size and Forecast
Orthopedic and Musculoskeletal Pain
Market Size and Forecast
General and Broad Pain Management
Market Size and Forecast
Surgical Pain Management
Market Size and Forecast
Migraine/Headache
Market Size and Forecast
Neuropathic Pain
Market Size and Forecast
Cancer Pain
Market Size and Forecast
Fibromyalgia Pain
Market Size and Forecast
Other Pain Types
Market Size and Forecast
Geographical Breakdown
Market Analysis by Region
Market Size and Forecast
North America
Market Size and Forecast
U.S.
Canada
Mexico
Europe
Market Size and Forecast
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Market Size and Forecast
China
Japan
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Size and Forecast
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Market Size and Forecast
South Africa
GCC Countries
Rest of the Middle East & Africa
Chapter 6 Competitive Intelligence
Introduction
Global Analysis of the Market and Its Leading Players
Agreements, Collaborations and Partnerships
2023 Device Approvals
Chapter 7 Sustainability
Importance of ESG in the Conventional and Alternative Pain Treatment Industry
ESG Practices in the Pain Treatment Medical Device Industry
Environmental Performance
Social Performance
Governance Performance
ESG Ranking
BCC Research Viewpoint
Chapter 8 Appendix
Research Methodology
References
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
BAXTER
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BOSTON SCIENTIFIC CORP.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
LILLY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.